Company newsMRNA
Explain this story: Biotech Stocks At 52-Week Highs - TKNO, MRNA, ATRC, ILMN
This article highlights several biotech stocks that reached 52-week highs on September 23, 2026, due to positive developments. Alpha Teknova Inc. (TKNO) saw growth from new products and increased revenue, while Moderna Inc. (MRNA) achieved highs after positive Phase 3 trial results for its melanoma treatment. AtriCure Inc. (ATRC) recorded strong revenue growth with its FDA-approved Afib treatments, and Illumina Inc. (ILMN) climbed due to significant revenue growth in genomics.
OtherRTTNewsSector and industry: HealthcareBiotechnologyTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
This article highlights several biotech stocks that reached 52-week highs on September 23, 2026, due to positive developments. Alpha Teknova Inc. (TKNO) saw growth from new products and increased revenue, while Moderna Inc. (MRNA) achieved highs after positive Phase 3 trial results for its melanoma treatment. AtriCure Inc. (ATRC) recorded strong revenue growth with its FDA-approved Afib treatments, and Illumina Inc. (ILMN) climbed due to significant revenue growth in genomics.
Article tone: Positive This describes the words the journalist used. It is not a prediction, and not advice.
Published Sep 24, 2026, 01:26 ET · on this site +3d